Polypharmacy Risk Detection
Polypharmacy Risk Detection is a computational method that identifies the likelihood of adverse health outcomes arising from the concurrent use of multiple medications by analyzing drug-drug interactions, patient-specific factors, and cumulative pharmacological effects within a clinical or pharmacovigilance context.
58
Publications
5.4K
Citations
298
Authors
160
Institutions
Publications per year
2017–2026
29
58
Danijela Gnjidic, Sarah N. Hilmer, Fiona Blyth et al. · Journal of Clinical Epidemiology · 2012 · 1.2K citations
Corinne M. Hohl, Jerrald Dankoff, Antoinette Colacone et al. · Annals of Emergency Medicine · 2001 · 480 citations
1–5 of 58
298
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 298
160

Karolinska Institutet
Stockholm, Sweden
3 h-index
6 publications
310 citations
Columbia University
New York, United States
2 h-index
2 publications
71 citations
Universidade de Santiago de Compostela
Santiago de Compostela, Spain
2 h-index
4 publications
99 citations

Boston Medical Center
Boston, United States
2 h-index
6 publications
102 citations

Royal North Shore Hospital
St Leonards, Australia
2 h-index
3 publications
2.4K citations
Diakonhjemmet Hospital
Oslo, Norway
2 h-index
3 publications
563 citations

The University of Sydney
Sydney, Australia
2 h-index
11 publications
11.8K citations

University of South Australia
Adelaide, Australia
2 h-index
4 publications
215 citations
1–8 of 160
3 publications · 78 citations
3
h-index
3 publications · 527 citations
3
h-index
3 publications · 505 citations
3
h-index
2 publications · 157 citations
2
h-index
2 publications · 247 citations
2
h-index
1–5